The Company Doctor

To limit the skyrocketing costs of their employees' health insurance, companies such as Dow, Chevron, and IBM, as well as many large HMOs, have increasingly hired physicians to supervise the medical care they provide. As Elaine Draper argues in The Company Doctor, company doctors are bound by two conflicting ideals: serving the medical needs of their patients while protecting the company's bottom line. Draper analyzes the advent of the corporate physician both as an independent phenomenon, and as an index of contemporary culture, reaching startling conclusions about the intersection of corporate culture with professional autonomy. Drawing on over 100 interviews with company physicians, scientists, and government and labor officials, as well as historical, legal, and statistical sources and medical trade association data, Draper presents an illuminating overview of the social context and meaning of professional work in corporations. Draper finds that while medical journals, speeches, and ethical codes proclaim the independent professional judgment of corporate physicians, the company doctors she interviewed often expressed anguish over the tightrope they must walk between their patients' health and the corporate oversight they face at every turn. Draper dissects the complex position occupied by company doctors to explore broad themes of doctor-patient trust, employee loyalty, privacy issues, and the future direction of medicine. She addresses such controversial topics as drug screening and the difficult position of company doctors when employees sue companies for health hazards in the workplace. Company doctors are but one example of professionals who have at times ceded their autonomy to corporate management. Physicians provide the prototypical professional case for exploring this phenomenon, due to their traditional independence, extensive training, and high levels of prestige. But Draper expands the scope of the book—tracing parallel developments in the law, science, and technology—to draw insightful conclusions about changing conditions in the professional workplace, as corporate cultures everywhere adapt to the new realities of the global economy. The Company Doctor provides a compelling examination of the corporatization of American medicine with far-reaching implications for professionals in many other fields.

NATIONAL BESTSELLER *SHORTLISTED FOR THE 2022 WRITERS' TRUST BALSILLIE PRIZE FOR PUBLIC POLICY* An urgently important exploration of the human stories behind Canada's evolving acceptance of Medical Assistance in Dying (MAiD), from one of its first and most thoughtful practitioners. Dr. Jean Marmoreo spent her career keeping people alive. But when the Supreme Court of Canada gave the green light to Medical Assistance in Dying (MAiD) in 2016, she became one of a small group of doctors who chose to immediately train themselves in this new field. Over the course of a single year, Marmoreo learns about end-of-life practices in bustling Toronto hospitals, in hospices, and in the facilities of smaller communities. She found that the needed services were often minimal—or non-existent. The Last Doctor recounts Marmoreo's crash course in MAiD and introduces a range of very different and memorable patients, some aged, some suffering from degenerative conditions or with a terminal disease, some surrounded by supportive love, some quite alone, who ask her help to end their suffering with dignity and on their own terms. Dr. Marmoreo also shares her own emotional transformation as she climbs a steep learning curve and learns the intimate truths of the vast range of end-of-life situations. What she experiences with MAiD shakes her to her core, makes her think deeply about pain, loneliness, and joy, and brings her closer to life’s most profound questions. At a time when end-of-life care and its quality are more in the public eye than ever before, The Last Doctor provides an accessibly personal, deeply humane, and authoritative guide through this difficult subject.

The book contains the results of research into primary sources and recent scholarship with an emphasis on leading personalities and anecdotes about them.

Doctors hold a pretty special place in our lives. They’re often there when we’re born, and they’re usually there when we die. They’re there for a lot of the scary or weird stuff that happens in between, too. In That’s Why I’m a Doctor, award-winning journalist Mark Bulgutch brings together forty-six stories from a diverse group of physicians, including pediatricians, interventional radiologists, general surgeons, psychiatrists, family doctors, gastroenterologists, ophthalmologists, gynecologists, neurologists and more. Each doctor’s story describes the moment that left them thinking, “That’s why I became a doctor.” This volume includes stories of innovation (developing a treatment for cholera); rare and fascinating medical cases (the separation of conjoined twins); the less dramatic but still quietly satisfying times when the doctor was able to have a lasting positive impact on the life of a patient or their family; and, of course, those unexpected moments when the patient taught the doctor an important life lesson that would inform their practice for years to come. These stories, big and small, are tied together by a sense of caring. It’s impossible to read what these doctors have to say and not come away with a new understanding of what goes through the mind of the person on the other end of the stethoscope and how dedicated doctors must be to do what they do.

The Encyclopedic Reference of Public Health presents the most important definitions, principles and general perspectives of public health, written by experts of the different fields. The work includes more than 2,500 alphabetical entries. Entries comprise review-style articles, detailed essays and short definitions. Numerous figures and tables enhance understanding of this little-understood topic. Solidly structured and inclusive, this two-volume reference is an invaluable tool for clinical scientists and practitioners in academia, health care and industry, as well as students, teachers and interested laypersons.